Indian Gemcitabine Exporters: Complete Supplier Ranking with Market Share — 248 Manufacturers (2026) — TransData Nexus

Q: Who is the largest gemcitabine supplier from India?

FRESENIUS KABI ONCOLOGY LIMITED is the largest gemcitabine exporter from India with a 14.8% market share and export value of $6.9M.

Q: How many gemcitabine suppliers are there in India?

There are 248 active gemcitabine exporters in India, collectively shipping $46.5M worth of gemcitabine across 2,938 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top gemcitabine suppliers from India?

The top 5 gemcitabine suppliers from India — FRESENIUS KABI ONCOLOGY LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 55.8% of total gemcitabine export value from India.

Suresh Sormare

Gemcitabine

India Pharmaceutical Trade Intelligence

$46.5M248 Suppliers125 CountriesHS 30049049

ExportsIndia → UNITED STATES16.8%India → BELGIUM12.7%

ImportsUNITED STATES → India$133.8M FRANCE → India$35.5M

#1 Supplier: FRESENIUS KABI #1 Buyer: YUSEN LOGISTICS

Gemcitabine Suppliers from India (2026) — 248 Exporters, $46.5M Market | TransData Nexus | TransData Nexus

Who Exports Gemcitabine from India — 248 Suppliers Behind a $46.5M Market

India's gemcitabine export market is supplied by 248 active exporters who collectively shipped $46.5M across 2,938 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 14.8% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 55.8% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Gemcitabine Suppliers & Exporters — 248 manufacturers, $46.5M export market, top destinations and formulations — Gemcitabine supplier data — 248 exporters · $46.5M market · 2,938 shipmentsTransData Nexus · Indian Customs Data

Top Gemcitabine Exporters from India — Ranked by Export Value

FRESENIUS KABI ONCOLOGY LIMITED is the leading gemcitabine exporter from India, holding a 14.8% share of the $46.5M market across 2,938 shipments from 248 exporters. The top 5 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED — collectively control 55.8% of total export value, indicating a moderately concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (14.8%), EUGIA PHARMA SPECIALITIES LIMITED (12.7%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (12.5%), MYLAN LABORATORIES LIMITED (8.0%), INTAS PHARMACEUTICALS LIMITED (7.9%).

Top Gemcitabine Exporters from India

Ranked by export value · 248 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Gemcitabine Exporters from India — Ranked by Export Value. 248 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Gemcitabine exporters

Certification and compliance status for top Gemcitabine suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
FRESENIUS KABI ONCOLOGY LIMITED	Approved	Yes	Yes	1	FDA approval for Bortezomib 3.5mg/vial on May 2, 2022.
MYLAN LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	WHO prequalification for Dolutegravir 50mg tablet on October 31, 2018.
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	Multiple	FDA approval for Bosentan 62.5mg and 125mg tablets on April 26, 2019.
INTAS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	FDA approval for various generic drugs; specific details not found.
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED	Approved	Yes	Yes	Multiple	FDA approval for Bortezomib 3.5mg/vial on May 2, 2022.
VENUS REMEDIES LIMITED	Not Listed	Yes	Yes	None	WHO-GMP certification obtained; specific date not found.
NAPROD LIFE SCIENCES PRIVATE LIMITED	Not Listed	Yes	Yes	None	WHO-GMP certification obtained; specific date not found.
UNITED BIOTECH PRIVATE LIMITED	Not Listed	Yes	Yes	None	WHO-GMP certification obtained; specific date not found.

TransData Nexus reviewed the regulatory standing of 8 leading Gemcitabine exporters from India. 5 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Gemcitabine sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players such as Dr. Reddy's Laboratories, Aurobindo Pharma, and Natco Pharma. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a hub for pharmaceutical research and manufacturing.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region is home to prominent companies such as Alembic Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus Cadila Healthcare. Vadodara, in particular, has a rich history in pharmaceuticals, with Alembic Pharmaceuticals established there in 1907.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region hosts several pharmaceutical giants, including Sun Pharmaceutical Industries and Lupin Limited, which leverage the strategic location for efficient distribution and export operations.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Gemcitabine exporters from India

May 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for targeted oncology expansion

In May 2025, Sun Pharmaceutical Industries Limited completed its acquisition of Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, for USD 4.10 per share, with additional contingent value rights of up to USD 0.70 per share. The acquisition includes Unloxcyttm, the first FDA-approved anti-PD-L1 therapy for advanced cutaneous squamous cell carcinoma. - IMPACT: This acquisition strengthens Sun Pharma’s specialty oncology portfolio, potentially enhancing its Gemcitabine export capabilities.

Impact: This acquisition strengthens Sun Pharma’s specialty oncology portfolio, potentially enhancing its Gemcitabine export capabilities.

October 21, 2025

M&A

Intas Pharmaceuticals Limited — Accord Plasma (Intas) acquires Prothya Biosolutions

Accord Plasma, a subsidiary of Intas Pharmaceuticals, completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. The deal adds Prothya’s European plasma fractionation facilities and collection network to Accord’s global plasma manufacturing footprint, expanding production and access to plasma-derived medicines. - IMPACT: This acquisition enhances Intas Pharmaceuticals' manufacturing capabilities, which may positively influence its Gemcitabine export operations.

Common Questions — Gemcitabine Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which gemcitabine supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, FRESENIUS KABI ONCOLOGY LIMITED leads with 339 recorded shipments worth $6.9M. EUGIA PHARMA SPECIALITIES LIMITED (188 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (137 shipments) are also established high-volume exporters.

Q How many gemcitabine manufacturers are there in India?

India has 248 active gemcitabine exporters with a combined export market of $46.5M across 2,938 shipments to 125 countries. The top 5 suppliers hold 55.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for gemcitabine from India?

Average FOB unit price: $10.70 per unit, ranging from $0.03 to $2290.14. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Gemcitabine

Gemcitabine

Who Exports Gemcitabine from India — 248 Suppliers Behind a $46.5M Market

Top Gemcitabine Exporters from India — Ranked by Export Value

Top Gemcitabine Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for targeted oncology expansion

Intas Pharmaceuticals Limited — Accord Plasma (Intas) acquires Prothya Biosolutions

Common Questions — Gemcitabine Suppliers from India

Q Which gemcitabine supplier from India is the most reliable for bulk orders?

Q How many gemcitabine manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for gemcitabine from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Eugia Pharma Specialities Limited — Eugia Pharma receives USFDA approval for Everolimus Tablets

Analysis Methodology